Literature DB >> 9181379

Lyme borreliosis--an overdiagnosed disease?

B Svenungsson1, G Lindh.   

Abstract

Ninety-nine patients who were referred to a clinic for infectious diseases on suspicion of Lyme borreliosis and whose major symptoms were fatigue, headache, myalgia and arthralgia were studied retrospectively to find out if there was any difference in symptomatology between patients who were seropositive or seronegative to Borrelia burgdorferi. 64/82 (78%) patients remembered one or more tick bites during previous years and 32/74 (43%) patients had a history of erythema migrans. Fatigue, headache, myalgia and arthralgia occurred in 84%, 72%, 54%, and 63% of the patients, respectively. 62/99 (63%) patients had an elevated IgM and/or IgG antibody titer to B. burgdorferi. There was no difference in frequency of symptoms between seropositive and seronegative individuals. 48/99 (49%) patients were treated with antibiotics, mostly oral doxycycline. Only 50% were improved after treatment. On follow-up 2 to 4 years after the first visit, 40% of the patients had recovered completely, 31% were improved, 24% reported unaltered symptoms and four patients were impaired. There was no difference in symptoms on follow-up between seropositive or seronegative patients. It is concluded that there probably is an overdiagnosis of Lyme borreliosis and that better microbiological methods are needed to confirm active disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9181379     DOI: 10.1007/BF02113600

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  30 in total

Review 1.  Lyme borreliosis: basic science and clinical aspects.

Authors:  H W Pfister; B Wilske; K Weber
Journal:  Lancet       Date:  1994-04-23       Impact factor: 79.321

2.  Summary of the first 100 patients seen at a Lyme disease referral center.

Authors:  L H Sigal
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

3.  Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis.

Authors:  R W Lightfoot; B J Luft; D W Rahn; A C Steere; L H Sigal; D C Zoschke; P Gardner; M C Britton; R L Kaufman
Journal:  Ann Intern Med       Date:  1993-09-15       Impact factor: 25.391

4.  Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings.

Authors:  F Strle; V Preac-Mursic; J Cimperman; E Ruzic; V Maraspin; M Jereb
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

Review 5.  Current status of laboratory diagnosis for Lyme disease.

Authors:  L A Magnarelli
Journal:  Am J Med       Date:  1995-04-24       Impact factor: 4.965

6.  Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis.

Authors:  M Karlsson; K Hovind-Hougen; B Svenungsson; G Stiernstedt
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

7.  Borrelia burgdorferi reactivity in patients with severe persistent fatigue who are from a region in which Lyme disease is endemic.

Authors:  P K Coyle; L B Krupp; C Doscher; K Amin
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

8.  Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study.

Authors:  S Hammers-Berggren; K Hansen; A M Lebech; M Karlsson
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

9.  Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis.

Authors:  S Hammers-Berggren; A M Lebech; M Karlsson; B Svenungsson; K Hansen; G Stiernstedt
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

Review 10.  Lyme disease: an infectious and postinfectious syndrome.

Authors:  E S Asch; D I Bujak; M Weiss; M G Peterson; A Weinstein
Journal:  J Rheumatol       Date:  1994-03       Impact factor: 4.666

View more
  5 in total

1.  Identifying diagnostic peptides for lyme disease through epitope discovery.

Authors:  G A Kouzmitcheva; V A Petrenko; G P Smith
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Patterns of Lyme disease diagnosis and treatment by family physicians in a southeastern state.

Authors:  John M Boltri; Robert B Hash; Robert L Vogel
Journal:  J Community Health       Date:  2002-12

3.  Using administrative medical claims data to supplement state disease registry systems for reporting zoonotic infections.

Authors:  Stephen G Jones; Steven Coulter; William Conner
Journal:  J Am Med Inform Assoc       Date:  2012-07-18       Impact factor: 4.497

Review 4.  Tick-borne encephalopathies : epidemiology, diagnosis, treatment and prevention.

Authors:  Göran Günther; Mats Haglund
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome.

Authors:  M F Seidel; A Belda Domene; H Vetter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.